Antibiotics
Catalog | Product Name / CAS / Description | Structure |
---|---|---|
BBF-02687 |
Thiomarinol A (146697-04-3) Inquiry |
|
Thiomarinol A is produced by a marine bacterium Alteromonas rava SANK T3390. It is resistant to Gram-positive and Gram-negative bacteria and also has an effect on MRSA. |
||
BBF-02688 | ||
Thiomarinol B is produced by a marine bacterium Alteromonas rava SANK T3390. It is resistant to Gram-positive and Gram-negative bacteria and also has an effect on MRSA. |
||
BBF-02689 | ||
Thiomarinol D is produced by a marine bacterium Alteromonas rava SANK T3390. It is resistant to Gram-positive and Gram-negative bacteria and also has an effect on MRSA. |
||
BBF-02690 | ||
Thiomarinol E is produced by a marine bacterium Alteromonas rava SANK T3390. It is resistant to Gram-positive and Gram-negative bacteria and also has an effect on MRSA. |
||
BBF-02691 |
Thiotetromycin (85263-97-4) Inquiry |
|
It is originally isolated from Str. sp. OM-674. Thiotetromycin has the effect of resisting anaerobe fragile bacteroidetes, and also resisting other bacteria, but the activity is weak. |
||
BBF-02692 |
Thioxamycin (124883-37-0) Inquiry |
|
Thioxamycin is produced by the strain of Str. sp. DP94. The minimum inducing concentration of X to the promoter TIP-1 was 80 ng/mL. |
||
BBF-02693 | ||
Thioactin is produced by the strain of Str. sp. DP94. The minimum inducing concentration of X to the promoter TIP-1 was 40 ng/mL. |
||
BBF-02694 |
Thrazarine (120128-14-5) Inquiry |
|
Thrazarine is produced by the strain of Str. coerulescens MH802 fF5. It inhibits DNA synthesis and the growth of tumor cells. |
||
BBF-02695 |
Tiacumicin A (109713-94-2) Inquiry |
|
It is originally isolated from Dactylosporangium aurantiacum sub sp. hamdenensis subsp. nov. AB718C-41. Tiacumicin A has the effect of resisting gram-positive bacteria. |
||
BBF-02696 |
Tiacumicin C (106008-70-2) Inquiry |
|
It is originally isolated from Dactylosporangium aurantiacum sub sp. hamdenensis subsp. nov. AB718C-41. Tiacumicin C has the effect of resisting gram-positive bacteria. |
||
BBF-02697 |
Tiacumicin F (106008-69-9) Inquiry |
|
It is originally isolated from Dactylosporangium aurantiacum sub sp. hamdenensis sub sp. nov. AB718C-41. Tiacumicin C has the effect of resisting gram-positive bacteria. It also has the activity of inhibiting pathogenic Staphylococcus aureus and multi-dose drug-resistant bacteria. |
||
BBF-02698 |
Tolypomycin Y (23412-26-2) Inquiry |
|
Tolypomycin Y is produced by the strain of Str. tolypophorus B2847. It has a broad-spectrum antimicrobial effect, which protects mice infected with gram-positive bacteria, and also has an inhibitory effect on vaccine virus. |
||
BBF-02699 |
Tolypomycin R (33889-22-4) Inquiry |
|
Tolypomycin R is produced by the strain of Str. tolypophorus B2847. It has a broad-spectrum antimicrobial effect, which protects mice infected with gram-positive bacteria, and also has an inhibitory effect on vaccine virus. |
||
BBF-02705 |
Trehalosamine (27208-79-3) Inquiry |
|
Trehalosamine is a carbohydrate antibiotic originally isolated from Str. sp. It has anti-gram-positive bacteria and Pseudomonas aeruginosa and mycobacterium action. |
||
BBF-02706 |
3-Trehalosamine (75060-25-2) Inquiry |
|
3-Trehalosamine is originally isolated from Nocardiopsis trehalosis sp. nov. NRRL 12026. It has a weak anti-Gram-positive bacteria effect. |
||
BBF-02713 |
Trichothecin (6379-69-7) Inquiry |
|
Trichothecin has anti-fungal and protozoal effects and it's produced by the strain of Trichothecium roseum. |
||
BBF-02714 |
Trichoviridin (56283-32-0) Inquiry |
|
It is originally isolated from Trichoderma viride. Trichoviridin has anti-bacterial and fungal effects. |
||
BBF-02715 |
Tridecaptin A (67922-28-5) Inquiry |
|
It is an antibiotic with antimicrobial properties produced by the strain of Bacillus polymyxa AR-110. |
||
BBF-02716 |
Tridecaptin C (67922-31-0) Inquiry |
|
It is an antibiotic with antimicrobial properties produced by the strain of Bacillus polymyxa B-2. |
||
BBF-02717 |
Triostin A (13758-27-5) Inquiry |
|
The compound of triosteomycin exhibited anti-gram-positive bacteria and mycobacteria, and had a strong inhibitory effect on Miyono adenocarcinoma, Ridgway osteosarcoma, Mecca lymphoid sarcoma and leukemia. |